This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Yumiko Suda: Innovator in Pharmaceutical Composition
Introduction
Yumiko Suda is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug compositions. Her innovative work has led to the creation of a patented pharmaceutical composition that enhances drug solubility and absorbability.
Latest Patents
Yumiko Suda holds a patent for a pharmaceutical composition for oral administration. The patent discloses a composition comprising 1-{5-[(5-{[(2R)-2-ethylpyrrolidin-1-yl]methyl}-4-[4-methoxy-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl)carbamoyl]pyrazin-2-yl}pyperidine-4-carboxylic acid, which is a compound with pH-dependent solubility, or a pharmaceutically acceptable salt thereof, along with a cellulose derivative. This composition significantly improves the solubility and absorbability of the drug.
Career Highlights
Yumiko Suda is currently associated with Astellas Pharma GmbH, where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new therapeutic options that can benefit patients worldwide.
Collaborations
Yumiko has collaborated with notable colleagues, including Toshiro Sakai and Kumi Naiki. These partnerships have fostered a collaborative environment that enhances the research and development of innovative pharmaceutical solutions.
Conclusion
Yumiko Suda's contributions to pharmaceutical compositions exemplify her dedication to improving drug efficacy. Her innovative spirit and collaborative efforts continue to make a significant impact in the field of pharmaceuticals.